D T Laskowitz|D M Lee|D Schmechel|H F Staats

Showing results (1-10 of 273) with videos related to

Pageof 28

Sort By:

Journal of Lipid Research|April 1, 2000

Altered immune responses in apolipoprotein E-deficient miceD T Laskowitz, D M Lee, D Schmechel, et al.

Neuroreport|April 29, 1998

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide productionD T Laskowitz, W D Matthew, E R Bennett, et al.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 1998

Apolipoprotein E and the CNS response to injuryD T Laskowitz, K Horsburgh, A D Roses

Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999

IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogensH F Staats, F A Ennis

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993

Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapyH F Staats, R N Lausch

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007

Serum markers of cerebral ischemiaD T Laskowitz, H Grocott, A Hsia, et al.

Journal of Neuroscience Methods|June 24, 1999

Characterization of a recovery global cerebral ischemia model in the mouseH Sheng, D T Laskowitz, R D Pearlstein, et al.

Journal of Neuroimmunology|June 1, 1997

Apolipoprotein E suppresses glial cell secretion of TNF alphaD T Laskowitz, S Goel, E R Bennett, et al.

AIDS Research and Human Retroviruses|July 20, 1997

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responsesH F Staats, S P Montgomery, T J Palker

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 31, 2015

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunityD Bento, H F Staats, T Gonçalves, et al.

Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:

Pageof 28

Journal of Lipid Research|April 1, 2000

Altered immune responses in apolipoprotein E-deficient miceD T Laskowitz, D M Lee, D Schmechel, et al.

Neuroreport|April 29, 1998

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide productionD T Laskowitz, W D Matthew, E R Bennett, et al.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 1998

Apolipoprotein E and the CNS response to injuryD T Laskowitz, K Horsburgh, A D Roses

Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999

IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogensH F Staats, F A Ennis

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993

Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapyH F Staats, R N Lausch

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007

Serum markers of cerebral ischemiaD T Laskowitz, H Grocott, A Hsia, et al.

Journal of Neuroscience Methods|June 24, 1999

Characterization of a recovery global cerebral ischemia model in the mouseH Sheng, D T Laskowitz, R D Pearlstein, et al.

Journal of Neuroimmunology|June 1, 1997

Apolipoprotein E suppresses glial cell secretion of TNF alphaD T Laskowitz, S Goel, E R Bennett, et al.

AIDS Research and Human Retroviruses|July 20, 1997

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responsesH F Staats, S P Montgomery, T J Palker

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 31, 2015

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunityD Bento, H F Staats, T Gonçalves, et al.

Pageof 28